Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3761872014 | Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3761873016 | Risedronate sodium 35 mg gastro-resistant oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4557131000052110 | risedronatnatrium 35 milligram, enterotablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | risedronatnatrium | false | Inferred relationship | Some | ||
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has active ingredient | Risedronate sodium (substance) | false | Inferred relationship | Some | ||
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has manufactured dose form | tablett med fördröjd frisättning | false | Inferred relationship | Some | ||
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has manufactured dose form | Gastro-resistant oral tablet (dose form) | true | Inferred relationship | Some | ||
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has precise active ingredient | Risedronate sodium (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Product containing only risedronic acid in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | har täljarvärde som visar styrka | 35 | false | Inferred relationship | Some | 1 | |
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has basis of strength substance (attribute) | Risedronate sodium (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely risedronate sodium 35 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR